BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
24
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Bioline Rx Ltd - ADR market cap is $4.8M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bioline Rx Ltd - ADR 52 week high is $3.95 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Bioline Rx Ltd - ADR 52 week low is $0.78 as of November 22, 2026.
Bioline Rx Ltd - ADR stock price today is $0.9639.
Bioline Rx Ltd - ADR stock price yesterday was $1.06.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Bioline Rx Ltd - ADR's P/E ratio is -0.53.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Bioline Rx Ltd - ADR P/B ratio is 0.3058.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Bioline Rx Ltd - ADR 50-day moving average is $2.02.